The archway phase 3 trial of the port delivery system with ranibizumab for neovascular age-related macular degeneration: Data update and surgical learnings
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要